SOBEGAPHARMA
ActiveSummary
SOBEGAPHARMA has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €187k and a net result of €24k. Equity is growing by ~26% per year across the filed fiscal years. Its solvency ranks better than 20% of 65 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability72=
Solvency43▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity tight (current ratio 1.14 against 1.04 in 2024; short-term debt: 49.7% and cash: 10.5% of total assets), and 81.9% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
18.1%
Return on assets
2.3%
Age of the figures
15 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 65 sector peers (2025).
NBB · sector comparisonPosition among 65 sector peers
Solvency
better than 20%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 01-02-2026, 1 day later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
1 d late
2024
17 d late
2023
14 d late
2022
28 d late
2021
3 d late
2020
13 d late
2019
21 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close25-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€24k▲ 0.2%
2024 · €24k
2019: €-4k
2020: €61k▲ +1750% vs 2019
2021: €89k▲ +46.6% vs 2020highest in 7 years
2022: €86k▼ -3.8% vs 2021
2023: €-13k▼ -116% vs 2022lowest in 7 years
2024: €24k▲ +281% vs 2023
2025: €24k▲ +0.2% vs 2024
2019 → 2025
Working capital
€73k▲ 273%
2024 · €20k
2019: €-101klowest in 7 years
2020: €-83k▲ +18.4% vs 2019
2021: €-49k▲ +40.7% vs 2020
2022: €27k▲ +155% vs 2021
2023: €-37k▼ -236% vs 2022
2024: €20k▲ +154% vs 2023
2025: €73k▲ +273% vs 2024highest in 7 years
2019 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€67k-€152k▲ 129%€139k▼ 8.8%€163k▲ 17.4%€187k▲ 14.9%
2021: €67klowest in 5 years
2022: €152k▲ +129% vs 2021
2023: €139k▼ -8.8% vs 2022
2024: €163k▲ +17.4% vs 2023
2025: €187k▲ +14.9% vs 2024highest in 5 years
Operating result€105k-€120k▲ 14.6%€22k▼ 82.0%€63k▲ 192%€30k▼ 52.8%
2021: €105k
2022: €120k▲ +14.6% vs 2021highest in 5 years
2023: €22k▼ -82.0% vs 2022lowest in 5 years
2024: €63k▲ +192% vs 2023
2025: €30k▼ -52.8% vs 2024
Net result€89k-€86k▼ 3.8%€-13k€24k€24k▲ 0.2%
2021: €89khighest in 5 years
2022: €86k▼ -3.8% vs 2021
2023: €-13k▼ -116% vs 2022lowest in 5 years
2024: €24k▲ +281% vs 2023
2025: €24k▲ +0.2% vs 2024
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 53% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.04M
Fixed assets
€448k ▼ 19.3%
Current assets
€588k ▲ 11.7%
Equity and liabilities €1.04M
Equity
€187k ▲ 14.9%
Debt
€848k ▼ 7.6%
Debt's share of the balance-sheet total falls from 84.9% to 81.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€144k▼
2024 · €181k
Cash flow
€138k▼
2024 · €142k
Current ratio
1.14▲
2024 · 1.04
Quick ratio
0.82▲
2024 · 0.73
Debt to equity
4.53▼
2024 · 5.63
ROE
12.9%▼
2024 · 14.8%
ROA
2.3%▲
2024 · 2.2%
Interest coverage
8.56▼
2024 · 9.40
Debt ≤ 1 year
€515k▲
2024 · €507k
Debt > 1 year
€333k▼
2024 · €411k
Income taxes
€-6k▼
2024 · €24k
Staff costs
€35k▲
2024 · €33k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.08M€1.04M▼
Fixed assets21/28€555k€448k▼
Intangible fixed assets21€10k-
Tangible fixed assets22/27€545k€448k▼
Land and buildings22€519k€429k▼
Plant, machinery and equipment23€15k€13k▼
Furniture and vehicles24€11k€6k▼
Current assets29/58€526k€588k▲
Stocks and contracts in progress3€154k€165k▲
Stocks30/36€154k€165k▲
Amounts receivable within one year40/41€260k€267k▲
Trade receivables40€96k€88k▼
Other amounts receivable41€164k€179k▲
Current investments50/53€20k€46k▲
Cash at bank and in hand54/58€91k€108k▲
Deferred charges and accrued income490/1€2k€2k=
Equity and liabilities
Total equity and liabilities10/49€1.08M€1.04M▼
Equity10/15€163k€187k▲
Contributions10/11€6k€6k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Profit (loss) carried forward14€155k€179k▲
Amounts payable17/49€918k€848k▼
Amounts payable after more than one year17€411k€333k▼
Financial debts170/4€411k€333k▼
Amounts payable within one year42/48€507k€515k▲
Current portion of amounts payable after more than one year42€91k€86k▼
Financial debts43€75k€75k=
Credit institutions430/8€75k€75k=
Trade debts44€261k€288k▲
Suppliers440/4€261k€288k▲
Other amounts payable47/48€80k€65k▼
Income statement
Code20242025
Non-recurring operating income76A€4k-
Remuneration, social security and pensions62€33k€35k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€117k€114k▼
Other operating charges640/8€4k€3k▼
Non-recurring operating charges66A€494€713▲
Gross operating margin9900€218k€183k▼
Operating profit (loss)9901€63k€30k▼
Financial income75/76B€4k€6k▲
Recurring financial income75€4k€6k▲
Financial charges65/66B€19k€17k▼
Recurring financial charges65€19k€17k▼
Profit (loss) for the period before taxes9903€48k€19k▼
Income taxes67/77€24k€-6k▼
Profit (loss) for the period9904€24k€24k▲
Profit (loss) for the period to be appropriated9905€24k€24k▲
Appropriation of the result
Profit (loss) to be appropriated9906€155k€179k▲
Profit (loss) brought forward from the previous period14P€131k€155k▲
Social balance
Average headcount (FTE)90870.80.8=
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | €4k | - | - |
| Remuneration, social security and pensions62 | - | €24k | €28k | €33k | €35k | ▲ 8.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €40k | €45k | €96k | €117k | €114k | ▼ 3.2% |
| Other operating charges640/8 | - | €4k | €4k | €4k | €3k | ▼ 4.5% |
| Non-recurring operating charges66A | - | €331 | €1k | €494 | €713 | ▲ 44.3% |
| Gross operating margin9900 | €182k | €193k | €150k | €218k | €183k | ▼ 15.8% |
| Operating profit (loss)9901 | €105k | €120k | €22k | €63k | €30k | ▼ 52.8% |
| Financial income75/76B | - | €4k | €5k | €4k | €6k | ▲ 29.0% |
| Recurring financial income75 | €7k | €4k | €5k | €4k | €6k | ▲ 29.0% |
| Financial charges65/66B | - | €17k | €16k | €19k | €17k | ▼ 12.8% |
| Recurring financial charges65 | €12k | €17k | €16k | €19k | €17k | ▼ 12.8% |
| Profit (loss) for the period before taxes9903 | €100k | €108k | €11k | €48k | €19k | ▼ 61.3% |
| Income taxes67/77 | €11k | €22k | €24k | €24k | €-6k | ▼ 123% |
| Profit (loss) for the period9904 | €89k | €86k | €-13k | €24k | €24k | ▲ 0.2% |
| Profit (loss) for the period to be appropriated9905 | €89k | €86k | €-13k | €24k | €24k | ▲ 0.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €938k | €948k | €1.18M | €1.08M | €1.04M | ▼ 4.2% |
| Fixed assets21/28 | €446k | €437k | €668k | €555k | €448k | ▼ 19.3% |
| Intangible fixed assets21 | €41k | €31k | €20k | €10k | - | - |
| Tangible fixed assets22/27 | €405k | €406k | €648k | €545k | €448k | ▼ 17.8% |
| Land and buildings22 | - | €361k | €608k | €519k | €429k | ▼ 17.3% |
| Plant, machinery and equipment23 | - | €16k | €20k | €15k | €13k | ▼ 14.0% |
| Furniture and vehicles24 | - | €29k | €20k | €11k | €6k | ▼ 49.1% |
| Current assets29/58 | €493k | €511k | €513k | €526k | €588k | ▲ 11.7% |
| Stocks and contracts in progress3 | €130k | €138k | €149k | €154k | €165k | ▲ 6.6% |
| Stocks30/36 | - | €138k | €149k | €154k | €165k | ▲ 6.6% |
| Amounts receivable within one year40/41 | €211k | €199k | €226k | €260k | €267k | ▲ 2.8% |
| Trade receivables40 | - | €69k | €86k | €96k | €88k | ▼ 8.5% |
| Other amounts receivable41 | - | €130k | €140k | €164k | €179k | ▲ 9.5% |
| Current investments50/53 | €56k | €67k | €45k | €20k | €46k | ▲ 134% |
| Cash at bank and in hand54/58 | €95k | €107k | €92k | €91k | €108k | ▲ 19.6% |
| Deferred charges and accrued income490/1 | - | - | - | €2k | €2k | = |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €938k | €948k | €1.18M | €1.08M | €1.04M | ▼ 4.2% |
| Equity10/15 | €67k | €152k | €139k | €163k | €187k | ▲ 14.9% |
| Contributions10/11 | - | €6k | €6k | €6k | €6k | = |
| Reserves13 | €2k | €2k | €2k | €2k | €2k | = |
| Non-distributable reserves130/1 | - | €2k | €2k | €2k | €2k | = |
| Reserves not available under the articles1311 | - | €2k | €2k | €2k | €2k | = |
| Profit (loss) carried forward14 | €58k | €144k | €131k | €155k | €179k | ▲ 15.6% |
| Amounts payable17/49 | €872k | €796k | €1.04M | €918k | €848k | ▼ 7.6% |
| Amounts payable after more than one year17 | €330k | €312k | €493k | €411k | €333k | ▼ 19.0% |
| Financial debts170/4 | - | €312k | €493k | €411k | €333k | ▼ 19.0% |
| Amounts payable within one year42/48 | €542k | €484k | €550k | €507k | €515k | ▲ 1.6% |
| Current portion of amounts payable after more than one year42 | - | €40k | €92k | €91k | €86k | ▼ 4.9% |
| Financial debts43 | - | €75k | €75k | €75k | €75k | = |
| Credit institutions430/8 | - | €75k | €75k | €75k | €75k | = |
| Trade debts44 | €232k | €261k | €262k | €261k | €288k | ▲ 10.5% |
| Suppliers440/4 | - | €261k | €262k | €261k | €288k | ▲ 10.5% |
| Other amounts payable47/48 | - | €108k | €120k | €80k | €65k | ▼ 18.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €89k | €86k | €-13k | €24k | €24k | ▲ 0.2% |
| + Depreciation and write-downs630 | €40k | €45k | €96k | €117k | €114k | ▼ 3.2% |
| Operating cash flow (approximation) | €129k | €130k | €82k | €142k | €138k | ▼ 2.6% |
| Investment in fixed assets (approximation) | - | €-36k | €-327k | €-4k | €-6k | ▼ 70.9% |
| Change in cash | - | €12k | €-14k | €-2k | €18k | ▲ 1,100% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-02
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 1 day late
2025
17-02
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 17 days late
2024
30-06
Financial
Back to profitnet €24k
Net result €24k after one loss-making year.
30-06
Financial
Equity above €150kEq €163k ▲17.4%
Equity rises from €139k to €163k.
14-02
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 14 days late
2023
30-06
Financial
Weakest financial yearnet €-13k
Net result drops to €-13k, the lowest in the series; recovery starts the following year.
28-02
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 28 days late
2022
30-06
Financial
Equity above €150kEq €152k ▲129%
3 profitable years in a row build equity to €152k.
03-02
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 3 days late
2021
30-06
Financial
Highest result since 2019net €89k ▲46.6%
Net result €89k, the highest in the series.
13-02
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 13 days late
2020
30-06
Financial
Back to profitnet €61k
Net result €61k after one loss-making year.
Show earlier events
21-02
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 21 days late
2019
31-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
23-02
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 23 days late
2017
27-02
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 27 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mons · 1 establishment unit since 2008
Ground area
157 m²
Building footprint
32 m²
Volume, LiDAR
372 m³
Parcel 53403F0415/00D000, Wallonia · tallest building 12.6 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Sobegapharma.
since 20082.171.131.402
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53403F0415/00D000 | Wallonia | 157 m² | 1 · 32 m² | 12.6 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
NO HEADACHE
BE 0430.126.506
Elsene · Eq €192k
MAKE IT WORK CONSULTING
BE 0784.837.589
Villers-la-Ville · Eq €210k
Montefalcone Projects
BE 0769.905.628
Maarkedal · Eq €163k
Asclepia MedChem Solutions
BE 0809.491.031
Destelbergen · Eq €161k
MEDIPHARM WORLDWIDE GROUP
BE 1017.902.558
Tienen · Eq €218k
Of 148 companies in sector 21100 we hold annual accounts for 108. 69 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded15-05-2008
Fiscal year end30-06
Activities, NACEBEL 2025
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
47730Retail sale of pharmaceutical products
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Scores and ratios are computed by Checked and are not a credit decision.